Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)
CAPS Rating:
A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.
RSS Headlines
Fool UK
Recs
Inexpensive and managements expansion plans seem bullish.